Protalix BioTherapeutics SG&A Expense (TTM) Analysis

Protalix BioTherapeutics Inc (PLX)

1.05 -0.02 (-1.87%) USD | NYAM | Sep 27, 16:00

1.055 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 1999. Upgrade now.

Date	Value
June 30, 2024	14.41M
March 31, 2024	14.96M
December 31, 2023	14.96M
September 30, 2023	13.91M
June 30, 2023	13.09M
March 31, 2023	11.67M
December 31, 2022	11.71M
September 30, 2022	12.08M
June 30, 2022	12.18M
March 31, 2022	12.74M
December 31, 2021	12.73M
September 30, 2021	12.21M
June 30, 2021	12.08M
March 31, 2021	11.10M
December 31, 2020	11.15M
September 30, 2020	11.21M
June 30, 2020	10.98M
March 31, 2020	10.86M
December 31, 2019	9.899M
September 30, 2019	9.057M
June 30, 2019	10.56M
March 31, 2019	10.65M
December 31, 2018	10.92M
September 30, 2018	12.09M
June 30, 2018	10.84M

Date	Value
March 31, 2018	11.49M
December 31, 2017	11.53M
September 30, 2017	11.33M
June 30, 2017	10.51M
March 31, 2017	9.898M
December 31, 2016	9.356M
September 30, 2016	7.508M
June 30, 2016	7.657M
March 31, 2016	7.452M
December 31, 2015	7.279M
September 30, 2015	7.925M
June 30, 2015	7.774M
March 31, 2015	7.339M
December 31, 2014	9.228M
September 30, 2014	9.275M
June 30, 2014	9.043M
March 31, 2014	9.659M
December 31, 2013	8.051M
September 30, 2013	8.475M
June 30, 2013	8.915M
March 31, 2013	10.24M
December 31, 2012	9.763M
September 30, 2012	8.97M
June 30, 2012	8.276M
March 31, 2012	6.571M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

9.057M

Minimum

Sep 2019

14.96M

Maximum

Dec 2023

12.15M

Average

12.08M

Median

SG&A Expense (TTM) Benchmarks